B. Özen Et Al. , "Evaluation of favipiravir use during pregnancy in women with covid-19 disease admitted to the outpatient clinics of medical pharmacology," 26. Ulusal 1. Uluslararsası Farmakoloji kongresi , vol.1, Turkey, pp.431, 2021
Özen, B. Et Al. 2021. Evaluation of favipiravir use during pregnancy in women with covid-19 disease admitted to the outpatient clinics of medical pharmacology. 26. Ulusal 1. Uluslararsası Farmakoloji kongresi , (Turkey), 431.
Özen, B., US, Z., GÜLHAN, R., YANANLI, H. R., KARAALP, A., GÜLÇEBİ İDRİZ OĞLU, M., ... ONAT, F.(2021). Evaluation of favipiravir use during pregnancy in women with covid-19 disease admitted to the outpatient clinics of medical pharmacology . 26. Ulusal 1. Uluslararsası Farmakoloji kongresi (pp.431). , Turkey
Özen, Berna Et Al. "Evaluation of favipiravir use during pregnancy in women with covid-19 disease admitted to the outpatient clinics of medical pharmacology," 26. Ulusal 1. Uluslararsası Farmakoloji kongresi, Turkey, 2021
Özen, Berna Et Al. "Evaluation of favipiravir use during pregnancy in women with covid-19 disease admitted to the outpatient clinics of medical pharmacology." 26. Ulusal 1. Uluslararsası Farmakoloji kongresi , Turkey, pp.431, 2021
Özen, B. Et Al. (2021) . "Evaluation of favipiravir use during pregnancy in women with covid-19 disease admitted to the outpatient clinics of medical pharmacology." 26. Ulusal 1. Uluslararsası Farmakoloji kongresi , Turkey, p.431.
@conferencepaper{conferencepaper, author={Berna Özen Et Al. }, title={Evaluation of favipiravir use during pregnancy in women with covid-19 disease admitted to the outpatient clinics of medical pharmacology}, congress name={26. Ulusal 1. Uluslararsası Farmakoloji kongresi}, city={}, country={Turkey}, year={2021}, pages={431} }